Drugscan
- Company typePrivate
- Founded1985
- HeadquartersHorsham, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
Drugscan firmographics
Firmographics- Name
- Drugscan
- Legal name
- DRUGSCAN, Inc.
- Website
- https://drugscan.com
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Drugscan industry classification
Industry- Product category
- Clinical Toxicology Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)
- akta.pro secondary industries
- Drug & Alcohol Testing Coordination (BPACALAE), Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring (HLAFALAN)
Keywords
Where Drugscan is headquartered
LocationHeadquarters
- HQ city
- Horsham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Drugscan business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- Clinical Laboratory Testing Services: Drug testing services including presumptive (screening) and definitive (confirmatory) tests billed using HCPCS codes (80307, G0480-G0483). Medicare payment based on established fee schedules with National Limitation Amounts.
- Healthcare Operations Support: Laboratory testing provided to physicians and healthcare professionals for treatment purposes, with billing for services rendered
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Presumptive Drug Test (HCPCS 80307) |
| Unit Pricing | Pay-as-you-go | Definitive Drug Tests, 1-7 Drug Classes (HCPCS G0480) |
| Unit Pricing | Pay-as-you-go | Definitive Drug Tests, 8-14 Drug Classes (HCPCS G0481) |
| Unit Pricing | Pay-as-you-go | Definitive Drug Tests, 15-21 Drug Classes (HCPCS G0482) |
| Unit Pricing | Pay-as-you-go | Definitive Drug Tests, 22+ Drug Classes (HCPCS G0483) |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Drugscan product offering
Product offeringCore offering
DRUGSCAN is a clinical toxicology laboratory providing drug and substance use disorder testing services. Its core offerings span presumptive (screening) and definitive (confirmatory) drug testing, prescription drug monitoring, substance use disorder management, workplace and law enforcement drug testing, and hospital/reference lab confirmation services. Testing is supported by reflex confirmation protocols using LCMSMS and GCMS, an extensive lab-developed test menu, online ordering and results portals, and direct access to PhD board-certified toxicologists.
Product overview
DRUGSCAN offers a unified toxicology and drug monitoring service portfolio centered on its core Drug Monitoring platform. The main offerings include Prescription Drug Monitoring, Substance Use Disorder Management, and Workplace Testing (with sub-services for Law Enforcement and Healthcare Professionals), all supported by Hospital and Reference Lab Services. Additional services like Virtual Specimen Collection and DOCTOX complement the testing workflow. As a CAP-accredited, SAMHSA-certified, and CLIA-licensed laboratory, the company delivers clinical excellence through confirmation testing, lab-developed tests, and toxicology expertise with time-saving technology tools.
Differentiator
Problem solved
Functional benefit
Brands
- DOCTOX: A specialized service offering for toxicology and drug monitoring.
Products and services
- Drug Monitoring Services Core toxicology and drug monitoring service providing tailored treatment plans and trusted testing for precise monitoring and actionable insights to support informed patient care for managing substance use disorders.
- Prescription Drug Monitoring
- Substance Use Disorder Management
- Workplace Testing and Monitoring
- Law Enforcement Testing
- Healthcare Professionals Testing
- Hospital and Reference Lab Services
- Virtual Specimen Collection
- DOCTOX
Quantifiable outcome
- Responsive toxicology enabling critical decision-making with speed, expertise and efficiency
Companies that use Drugscan
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Drugscan technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Drugscan partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- ACM Global LaboratoriescoreACM Global Laboratories is listed as a DRUGSCAN affiliate, indicating a shared corporate family or strategic relationship within the laboratory services ecosystem. The relationship suggests coordinated operations and shared expertise in toxicology and laboratory services.
- DSI Medical Services, Inc.coreDSI Medical Services, Inc. is listed as a DRUGSCAN affiliate, indicating a shared corporate family or strategic relationship. DSI Medical Services provides medical review officer services and is part of the ACM Global/DRUGSCAN network of laboratory affiliates.
- Rochester Regional HospitalcoreRochester Regional Hospital is listed as a DRUGSCAN affiliate. This relationship provides a clinical connection and referral network for laboratory testing services within the Rochester Regional Health system.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Drugscan competitors and assessment
Company assessmentOthers
- DSI Medical Services: Medical Review Officer (MRO) services provider listed as a DRUGSCAN affiliate within the RRH family. Adjacent rather than directly competitive; enables DRUGSCAN's workplace and professional-monitoring offerings to be delivered as an end-to-end MRO-plus-lab bundle.
- ACM Global Laboratories: Listed as a DRUGSCAN affiliate within the Rochester Regional Health network. While not a direct competitor, the affiliation creates both operational coordination opportunities and potential channel conflict worth noting as an ecosystem peer.
Direct peers
- Aegis Sciences Corporation: Specialized clinical laboratory focused on toxicology, drug monitoring, and pain-management/substance-use disorder testing. Like DRUGSCAN, Aegis operates as a high-complexity specialty tox lab serving healthcare providers, employers, and the criminal justice system.
- Millennium Health: Specialty toxicology laboratory providing definitive drug and alcohol testing for clinicians treating substance use disorders and chronic pain. Closely comparable to DRUGSCAN in clinical positioning, assay menu (LCMSMS-based confirmations), and primary customer set.
- Dominion Diagnostics: Specialty laboratory focused on medication monitoring, substance use disorder, and pain management toxicology testing. Shares DRUGSCAN's niche in clinician-ordered UDT and offers a directly overlapping test menu and customer base.
Broad incumbents
- Quest Diagnostics: National full-service clinical laboratory offering routine testing alongside workplace drug toxicology and pain management panels. Competes with DRUGSCAN for hospital reference lab work and employer accounts but offers a much broader non-tox menu and national PSC footprint.
- Laboratory Corporation of America (LabCorp): Largest U.S. clinical laboratory network with broad routine testing and a substantial workplace and clinical toxicology offering (including via MedTox). Competes with DRUGSCAN across hospital, employer, and physician tox ordering.
- ARUP Laboratories: National academic reference laboratory offering esoteric testing including toxicology and TDM. Comparable to DRUGSCAN at the high-complexity reference lab tier, particularly for hospital overflow confirmatory testing.
- Mayo Clinic Laboratories: Reference laboratory arm of Mayo Clinic offering broad esoteric and specialty testing, including toxicology. Comparable as a Center-of-Excellence-style reference lab to which hospitals send complex toxicology confirmations.
- Sonic Healthcare: Global diagnostics provider with U.S. lab operations offering clinical and workplace toxicology. Overlaps with DRUGSCAN in the workplace and clinical drug-testing category as part of a much broader lab portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Drugscan social profiles
Digital presenceDrugscan compliance and trust
Trust signalCompliance6 records
Drugscan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Drugscan leadership team
Management profileNumber of profiles
Profiles2 records
Drugscan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Drugscan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Drugscan
What does Drugscan do?
DRUGSCAN is a clinical toxicology laboratory providing drug and substance use disorder testing services. Its core offerings span presumptive (screening) and definitive (confirmatory) drug testing, prescription drug monitoring, substance use disorder management, workplace and law enforcement drug testing, and hospital/reference lab confirmation services. Testing is supported by reflex confirmation protocols using LCMSMS and GCMS, an extensive lab-developed test menu, online ordering and results portals, and direct access to PhD board-certified toxicologists.
Is Drugscan a public or private company?
Drugscan is a private company. It is classified as corporate owned and is currently operating.
When was Drugscan founded?
Drugscan was founded in 1985. It employs 101 to 250 people.
Where is Drugscan based?
Drugscan is headquartered in Horsham, United States, in the North America region.
How does Drugscan make money?
Two revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are healthcare Operations Support.
Who are Drugscan's main competitors?
Others on record are DSI Medical Services and ACM Global Laboratories. Direct peers are Aegis Sciences Corporation, Millennium Health and Dominion Diagnostics. Broad incumbents are Quest Diagnostics, Laboratory Corporation of America (LabCorp), ARUP Laboratories, Mayo Clinic Laboratories and Sonic Healthcare.
Does Drugscan have an API?
No public API is recorded for Drugscan.
What industry is Drugscan in?
Drugscan's product category is Clinical Toxicology Laboratory Services. Its primary akta.pro industry code is HLAFAMAF, Toxicology & Therapeutic Drug Monitoring Laboratories, with a secondary code of BPACALAE, Drug & Alcohol Testing Coordination. Its NAICS code is 621511 and its SIC code is 8071.